Related references
Note: Only part of the references are listed.Functional role of endothelial CXCL16/CXCR6-platelet-leucocyte axis in angiotensin II-associated metabolic disorders
Aida Collado et al.
CARDIOVASCULAR RESEARCH (2018)
High-Density Lipoprotein Reduction Differentially Modulates to Classical and Nonclassical Monocyte Subpopulations in Metabolic Syndrome Patients and in LPS-Stimulated Primary Human Monocytes In Vitro
Johanna L. Gruen et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
The Hunt for the Source of Primary Interleukin-4: How We Discovered That Natural Killer T Cells and Basophils Determine T Helper Type 2 Cell Differentiation In Vivo
Tomohiro Yoshimoto
FRONTIERS IN IMMUNOLOGY (2018)
C-reactive Protein Is Associated With Prevalence of the Metabolic Syndrome, Hypertension, and Diabetes Mellitus in US Adults
Mohsen Mazidi et al.
ANGIOLOGY (2018)
Monocyte Conversion During Inflammation and Injury
Rachel M. Kratofil et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Metabolic syndrome and the seminal cytokine network in morbidly obese males
A. Pilatz et al.
ANDROLOGY (2017)
PCSK9 inhibitors and foamy monocytes in familial hypercholesterolaemia
Huaizhu Wu et al.
NATURE REVIEWS CARDIOLOGY (2017)
Advanced atherosclerosis is associated with inflammation, vascular dysfunction and oxidative stress, but not hypertension
Quynh N. Dinh et al.
PHARMACOLOGICAL RESEARCH (2017)
Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges
Tin Kyaw et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease
Carolina N. Franca et al.
CLINICAL SCIENCE (2017)
CCL2 level is elevated with metabolic syndrome and CXCL10 level is correlated with visceral fat area in obese children
Masahiro Ishii et al.
ENDOCRINE JOURNAL (2016)
Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population
Krithika Srikanthan et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2016)
Postprandial Monocyte Activation in Individuals With Metabolic Syndrome
Ilvira M. Khan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Role and analysis of monocyte subsets in cardiovascular disease Joint consensus document of the European Society of Cardiology (ESC) Working Groups Atherosclerosis & Vascular Biology and Thrombosis
Christian Weber et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Endothelial cells microparticle-associated protein disulfide isomerase promotes platelet activation in metabolic syndrome
Guan-qi Fan et al.
ONCOTARGET (2016)
Impact of Obesity and Metabolic Syndrome on Immunity
Catherine J. Andersen et al.
ADVANCES IN NUTRITION (2016)
Modulation of platelet and monocyte function by the chemokine fractalkine (CX3CL1) in cardiovascular disease
Ulrike Flierl et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2015)
Chemokine CX3CL1 and its receptor CX3CR1 are associated with human atherosclerotic lesion volnerability
Xiaolin Zhang et al.
THROMBOSIS RESEARCH (2015)
Metabolic syndrome, platelet activation and the development of transient ischemic attack or thromboembolic stroke
Mia-Jeanne van Rooy et al.
THROMBOSIS RESEARCH (2015)
Inflammatory markers and cardiometabolic diseases
N. Esser et al.
ACTA CLINICA BELGICA (2015)
Eosinophils in vasculitis: characteristics and roles in pathogenesis
Paneez Khoury et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Peripheral CD4CD8 Double Positive T Cells with a Distinct Helper Cytokine Profile Are Increased in Rheumatoid Arthritis
Dagmar Quandt et al.
PLOS ONE (2014)
Platelets and their chemokines in atherosclerosis-clinical applications
Philipp von Hundelshausen et al.
FRONTIERS IN PHYSIOLOGY (2014)
Arterial and Venous Endothelia Display Differential Functional Fractalkine (CX(3)CL1) Expression by Angiotensin-II
Cristina Rius et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Association between CD8+T-cell subsets and cardiovascular disease
D. Kolbus et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Systemic Inflammation and Lung Function Impairment in Morbidly Obese Subjects with the Metabolic Syndrome
Astrid van Huisstede et al.
JOURNAL OF OBESITY (2013)
Metabolic syndrome (MetS) predicts cardio and cerebrovascular events in a twenty years follow-up. A prospective study
S. Novo et al.
ATHEROSCLEROSIS (2012)
Soluble CD40 ligand, soluble P-selectin and von Willebrand factor levels in subjects with prediabetes: The impact of metabolic syndrome
Halil Genc et al.
CLINICAL BIOCHEMISTRY (2012)
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Rafael Lozano et al.
LANCET (2012)
Fractalkine and Its Receptor (CX3CR1) in Patients with Stable Coronary Artery Disease and Diabetes Mellitus
Ida Unhammer Njerve et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2012)
Platelet activation in obesity and metabolic syndrome
F. Santilli et al.
OBESITY REVIEWS (2012)
The metabolic syndrome
Robert H. Eckel et al.
LANCET (2010)
Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight toss
S. Balducci et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2010)
Genetic diversity of CX3CR1 gene and coronary artery disease: New insights through a meta-analysis
Stavros Apostolakis et al.
ATHEROSCLEROSIS (2009)
Monocyte subtypes predict clinical course and prognosis in human stroke
Xabier Urra et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
Satish L. Deshmane et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2009)
Tumor necrosis factor-alpha up-regulates the expression of CCL2 and adhesion molecules of human proximal tubular epithelial cells through MAPK signaling pathways
Amy Wing Yin Ho et al.
IMMUNOBIOLOGY (2008)
CX3CR1 receptor is up-regulated in monocytes of coronary artery diseased patients: Impact of pre-inflammatory stimuli and renin-angiotensin system modulators
Stavros Apostolakis et al.
THROMBOSIS RESEARCH (2007)
Inflammation and metabolic disorders
Goekhan S. Hotamisligil
NATURE (2006)
The association of total and differential white blood cell count with metabolic syndrome in type 2 diabetic patients
Wan Sub Shim et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2006)
Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy
JK Damås et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Mechanisms of endothelial dysfunction in obesity
A Avogaro et al.
CLINICA CHIMICA ACTA (2005)
Hypercoagulability in the metabolic syndrome
M Nieuwdorp et al.
CURRENT OPINION IN PHARMACOLOGY (2005)
Significance of the level of monocyte chemoattractant protein-1 in human atherosclerosis - Assessment in chronic hemodialysis patients
KF Kusano et al.
CIRCULATION JOURNAL (2004)
Endothelial function - A critical determinant in atherosclerosis?
U Landmesser et al.
CIRCULATION (2004)
Fractalkine (CX3CL1) stimulated by nuclear factor κB (NF-κB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway
B Chandrasekar et al.
BIOCHEMICAL JOURNAL (2003)
Monocyte chemoattractant protein 1 in obesity and insulin resistance
P Sartipy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Chemokines and chemokine receptors in leukocyte trafficking
TS Olson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2002)
Share Paper
